Concepedia
Statistics
Publications
28
Citations
1.1K
H-Index
19
Active since
1988
Affiliations
University of Illinois Chicago(Current)
Noble Life Sciences (United States)
Huntsman Cancer Institute
Translational Genomics Research Institute
Georgetown University Medical Center
Stephen Horrigan is an author at University of Illinois Chicago specializing in life sciences, molecular oncology, and genetics.
Publications per year
1988–2023
Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31
Stephen Horrigan, Zarema Arbieva, Hong Yan Xie et al. · Blood · 2000 · 110 citations
Life Sciences, Genetics, Molecular Genetics +13
Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells
Warren Fiskus, S. Sharma, Saikat Saha et al. · Leukemia · 2014 · 96 citations · Full text
Medicine, Oncology, Pharmacology +14
The Smad5 Gene Is Involved in the Intracellular Signaling Pathways That Mediate the Inhibitory Effects of Transforming Growth Factor-β on Human Hematopoiesis
E Bruno, Stephen Horrigan, David Van Den Berg et al. · Blood · 1998 · 84 citations · Full text
Life Sciences, Hematology, Molecular Biology +14
A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31
Zhenbo Hu, Ignatius Gomes, Stephen Horrigan et al. · Oncogene · 2001 · 81 citations
Life Sciences, Genetics, Molecular Genetics +8
Characterization of an associated microfibril protein through recombinant DNA techniques.
Stephen Horrigan, Celeste B. Rich, Barbara W. Streeten et al. · Journal of Biological Chemistry · 1992 · 75 citations · Full text
Life Sciences, Genetics, Molecular Biology +15
1–5 of 28